<DOC>
	<DOC>NCT02946788</DOC>
	<brief_summary>This is a single center open label study intended to provide photo documentation and time to response data for BPX-01 1 and 2% minocycline topical gel for the treatment of moderate to severe non-nodular inflammatory acne vulgarism.</brief_summary>
	<brief_title>Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>moderate to severe inflammatory nonnodular acne vulgaris female subject who is breastfeeding, pregnant or planning a pregnancy during the study have other skin condition or disease that would interfere with the study have had any prior treatment with minocycline have a known or suspected allergy to tetracycline class products have used OTC medications for the treatment of facial acne within the last 14 days have used any prescription topical or oral medications for the treatment of facial acne in the last 28 days have had a facial procedure (chemical peel, dermabrasion, laser, etc) within the last 8 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>